Maximum quantity allowed is 999
请选择数量
CAS RN: 56390-09-1 | 產品號碼: E0840
Epirubicin Hydrochloride
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品規格
Appearance | Light yellow to Yellow to Orange powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Specific rotation | +310 to +340 deg(C=0.05, methanol)(calcd.on anh.substance) |
Water | max. 8.0 % |
性質
熔點 | 185 °C |
比旋光 [α]D | 310° (C=0.05,MeOH) |
Maximum Wavelength | 497(H2O) nm |
水溶性 | Slightly soluble |
溶解性(微溶於) | Methanol |
GHS
圖形表示 |
![]() ![]() |
信號詞 | Danger |
危險性說明 | H302 : Harmful if swallowed. H360 : May damage fertility or the unborn child. H340 : May cause genetic defects. H350 : May cause cancer. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P405 : Store locked up. |
相關法規
RTECS # | QI9295750 |
運輸資料
HS編碼* | 2941.90-000 |
Application
Epirubicin Hydrochloride: An Anthracycline Antibiotic Cytotoxic Agent with a Better Toxicity Profile
Epirubicin hydrochloride is the 4’-epimer of the anthracycline antibiotic cytotoxic agent, doxorubicin [D4193]. The precise mechanisms of epirubicin’s cytotoxic and/or antiproliferative properties have not been completely elucidated. However, it has been reported that epirubicin forms a complex with DNA by intercalation of its planar rings between nucleotide base pairs, with consequent inhibition of nucleic acid (DNA and RNA) and protein synthesis. After intercalation between DNA base pairs, epirubicin stabilizes the topoisomerase II-DNA complex, resulting in irreversible DNA strand breakage and cytocidal activity.1-3)
Epirubicin has been shown to have a better toxicity profile than doxorubicin. The formation of glucuronide conjugates, not seen with doxorubicin, is observed with epirubicin. The reason for this is thought to be the inversion of the OH group at the 4' position in epirubicin, which facilitates the reaction of glucuronyl transferase. This facilitates excretion and may contribute to the reduced toxicity of epirubicin compared to doxorubicin.4) In clinical, epirubicin hydrochloride has been used alone or in combination with other cytotoxic chemotherapeutic agents in the treatment of a variety of malignancies. (The product is for research purpose only.)
Epirubicin has been shown to have a better toxicity profile than doxorubicin. The formation of glucuronide conjugates, not seen with doxorubicin, is observed with epirubicin. The reason for this is thought to be the inversion of the OH group at the 4' position in epirubicin, which facilitates the reaction of glucuronyl transferase. This facilitates excretion and may contribute to the reduced toxicity of epirubicin compared to doxorubicin.4) In clinical, epirubicin hydrochloride has been used alone or in combination with other cytotoxic chemotherapeutic agents in the treatment of a variety of malignancies. (The product is for research purpose only.)
References
- 1) Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy
- 2) Epirubicin: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer
- 3) Epirubicin: is it like doxorubicin in breast cancer? A clinical review
- 4) Metabolism of 4′-modified analogs of doxorubicin. Unique glucuronidation pathway for 4’-epidoxorubicin
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。